Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Gains from Equity Investments (2019 - 2020)

Historic Gains from Equity Investments for Arcturus Therapeutics Holdings (ARCT) over the last 2 years, with Q2 2020 value amounting to $100000.0.

  • Arcturus Therapeutics Holdings' Gains from Equity Investments changed N/A to $100000.0 in Q2 2020 from the same period last year, while for Jun 2020 it was $551000.0, marking a year-over-year change of. This contributed to the annual value of $263000.0 for FY2020, which is 95200.0% up from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Gains from Equity Investments stood at $100000.0 for Q2 2020.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Gains from Equity Investments peaked at $288000.0 during Q1 2019, and registered a low of $100000.0 during Q2 2020.